Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2025-12-26 @ 1:16 PM
NCT ID: NCT00628706
Eligibility Criteria: Inclusion Criteria: * History of mild cannabis use for at least one year (\<1/week and ≥ 4/year) * History without psychotic experiences after cannabis use * Age between 18 and 45 years * Right-handedness, assessed with the Edinburgh Handedness Inventory * Written informed consent of the subject Exclusion Criteria: * Any clinical significant abnormality of any clinical laboratory test, including urinary drug screening * Impaired physical health evaluated by medical history, physical (including neurological) examination and screening laboratory tests * History of clinically significant psychiatric or neurological illness * History of clinically significant psychiatric or neurological illness in first- or second-degree relatives * History of alcohol and/or drug abuse (DSM-IV criteria) * Body Mass Index (B.M.I.) \<18 kg/m2 or \>28 kg/m2 * Paranoid ideation or psychoticism on SCL-90 * Any subject who received any investigational medication within 90 days prior to the start of the study or who is scheduled to receive an investigational drug * The use of any medication within three weeks prior to the start of the study, except for paracetamol * Positive HIV or Hepatitis B/C test * Blood donation within 3 months before the start of the study * Claustrophobia * Metal objects in or around the body (braces, pacemaker, metal fragments)
Healthy Volunteers: True
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 45 Years
Study: NCT00628706
Study Brief:
Protocol Section: NCT00628706